PSID Stock DD PositiveID Corp. 08/06/2014 19:56:37

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
PSID PositiveID Corp. $PSID Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=PSID&...mp;yt0=Go!

Last Updated: 08/06/2014 19:56:32

Current Price and Quotes
Last Price 0.0435
Previous Close 0.0421 Open 0.047
Daily Range N/A - 0.047 52wk Range 0.02 - 0.138
Volume 393,691 Dividend N/A
Average Vol (3m) 797,649 Yield N/A




Financials
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - 75
Cost of Revenue - - - 45
Gross Profit - - - 30
Operating Expenses

Research and Development 691 861 784 1,394
Sales, General and Admin. 4,132 6,541 15,728 9,722
Non-Recurring Items - 357 - -
Other - - - -
Operating Income (4,823) (7,759) (16,512) (11,086)
Income From Continuing Operations

Add'l Income/Expense Items 1,511 (54) 88 34
Earnings Before Interest and Tax (3,312) (7,813) (16,424) (11,052)
Interest Expense 646 180 - -
Earnings Before Tax (3,958) (7,993) (16,424) (11,052)
Income Tax 371 - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,329) (7,993) (16,424) (11,052)
Non Recurring Events

Discontinued Operations - - (57) (4,864)
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (4,329) (7,993) (16,481) (15,916)
Preferred Stock and Other Adjustments (9,007) (17,309) (221) (152)
Net Income Applicable to Common Shareholders (13,336) (25,302) (16,702) (16,068)

Recent News

Jul 23, 2014 PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
Jul 17, 2014 PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
Jul 1, 2014 PositiveID Corp. Chairman and CEO William J. Caragol Conducts New Interview with The Green Baron Report
Jun 30, 2014 PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
Jun 16, 2014 PositiveID's Chairman and CEO Discusses Progress with Bio-Threat Detection Technology and Revenue Guidance
Jun 11, 2014 In a New Audio Interview at SmallCapVoice.com, PositiveID Corporation Discusses Its Recently Announced Revenue Guidance of $4-10 Million Over the Next 18 Months
Jun 10, 2014 OTC Sector Trading List: Strategic Global Investments, Inc. Alkame Holdings, Inc. One World Holdings, Inc. Positiveid Corporation, Powerdyne International, Inc.
Jun 6, 2014 PositiveID Issues First-Ever Revenue Guidance of $4-10 Million Over Next 18 Months as Government Procurements for Bio-Threat Detection Increase
May 27, 2014 PositiveID Corporation Updates Stockholders on 2014 Progress
May 14, 2014 PositiveID Corporation to Present at the Third Annual Marcum MicroCap Conference

1
2
next >


PSID PositiveID Corp. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=PSID&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/PSID/quote
Stock Chart http://www.otcmarkets.com/stock/PSID/chart
Company Info http://www.otcmarkets.com/stock/PSID/company-info
Recent News http://www.otcmarkets.com/stock/PSID/news
Financials http://www.otcmarkets.com/stock/PSID/financials
Filings and Disclosure http://www.otcmarkets.com/stock/PSID/filings
Short Sales http://www.otcmarkets.com/stock/PSID/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/PSID/insider-transactions
Research Reports http://www.otcmarkets.com/stock/PSID/research
Summary http://finance.yahoo.com/q?s=PSID
Historical Prices http://finance.yahoo.com/q/hp?s=PSID+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=PSID
Basic Chart http://finance.yahoo.com/q/bc?s=PSID+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=PSID+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=PSID+Headlines
Press Releases http://finance.yahoo.com/q/p?s=PSID+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=PSID+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=PSID+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=PSID+Industry
Major Holders http://finance.yahoo.com/q/mh?s=PSID+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=PSID+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=PSID+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=PSID
Balance Sheet http://finance.yahoo.com/q/bs?s=PSID
Cash Flow http://finance.yahoo.com/q/cf?s=PSID+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/PSID
Market Watch http://www.marketwatch.com/investing/stock/PSID
Bloomberg http://www.bloomberg.com/quote/PSID:US
Morningstar http://quotes.morningstar.com/stock/s?t=PSID
Bussinessweek http://investing.businessweek.com/research/st...icker=PSID
Barchart http://www.barchart.com/quotes/stocks/PSID
OTC Short Report http://otcshortreport.com/index.php?index=PSID
Investopedia http://www.investopedia.com/markets/stocks/PSID/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Terminus Ballet: A Decade of Defying Dance Norms

Updated Category News Views 135

A Dance Company's Journey of Transformation An anniversary represents more than just a celebration; it's a reminder of the road traveled. On Jan. 30, 2027, Terminus Modern Ballet Theatre will mark its 10th anniversary, encapsulating a decade of defiance against the staid conventions binding classical ballet. This isn't just about pirouettes and pliés—it's dance with a...

Continue Reading
Bacterial Breakthrough in Cancer Therapy: Game Changer?

Updated Category News Views 35

Blurring Lines Between Bugs and Biotech Well, wouldn't you know it, the eggheads over at Jeonbuk National University in South Korea are at it again, pushing the boundaries of what these little bacterial buggers can do. This time, they’ve had a crack at cancer therapy, using engineered Salmonella to pack a double punch against breast cancer in mice. Now, if that ain't...

Continue Reading
Lennar Faces Securities Fraud Lawsuit: Investor Insights

Updated Category News Views 20

Investors in Lennar: Navigating the Legal Storm Hold onto your hats, folks. Lennar Corporation (NYSE: LEN) is up against it with a brand-spanking-new securities fraud lawsuit helmed by Schall, Brown & Schwartz LLP (SBS). This isn't just a couple of investors grumbling over cocktails; it’s a full-blown class action that’s waving the legal banner under the Securities...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 78

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Tenax Therapeutics Facing Class Action: DEC 28 Deadline

Updated Category News Views 70

Legal Storm Over Tenax Therapeutics Just what the doctor didn't order—legal headaches for Tenax Therapeutics, Inc. (NASDAQ:TENX). Yup, folks, buckle up because we're diving into another class action mudslinging match that’s setting the markets wagging. Berger Montague's law trebuchet is aimed squarely at Tenax and every investor should know the target’s outline....

Continue Reading
Graphic Packaging Shakes Up Leadership and Supply Chain

Updated Category News Views 29

New Leadership Takes the Helm at Graphic Packaging What do you do when you want to streamline an operation that spans continents? Well, if you're Graphic Packaging Holding Company (NYSE: GPK), you bring in fresh leadership to serenade the chaos into a well-oiled machine. Starting December 1, 2026, D. Keith Hamilton will be sinking his teeth into North America Mills &...

Continue Reading
Akeso's Gumokimab Wins NMPA Approval for AS Treatment

Updated Category News Views 194

Gumokimab Approved: A New Dawn in AS Treatment Yeah, the biotech world shifts gears today as Akeso's gumokimab received the green light from China's National Medical Products Administration (NMPA). This approval for treating ankylosing spondylitis, or AS, isn't just another checkbox for Akeso; it's a game-changer in tackling this chronic inflammatory disease. Why should...

Continue Reading
Sasol AGM Resolutions Passed in One Swift Swing

Updated Category News Views 119

Sasol's AGM Delivers Smooth Sailing for Shareholders Can't say I'm surprised, but Sasol's annual general meeting on the 13th of November went off without a hitch—unless, of course, you're one of those folks who just loves fireworks at these gatherings. The entire set of resolutions danced through with a resounding "Aye," making it one heck of a day for anyone banking on...

Continue Reading
ROBOTERA Debuts XHAND 1 Pro-U in NVIDIA Demo

Updated Category News Views 117

ROBOTERA Steps Up with XHAND 1 Pro-U Move over, traditional robotics; ROBOTERA is here to shake things up with their latest marvel, the XHAND 1 Pro-U. This futuristic gadget isn't just making waves at the Conference on Robot Learning (CoRL) where Jim Fan of NVIDIA spotlighted it in his GR00T 2 demo, it's setting a new bar for robotic dexterity. Hand in Glove with Human...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 59

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading

Top 5 Most Recently Viewed Articles

Ocuphire Pharma Faces Scrutiny Over Shareholder Obligations

Updated Category News Views 81

Ocuphire Pharma Under Investigation by Ademi LLP Recently, there have been growing concerns regarding the fiduciary responsibilities of Ocuphire Pharma, Inc. (NASDAQ: OCUP) to its public shareholders. Ademi LLP has initiated an investigation focused on whether the company is adequately protecting the interests of its shareholders amidst its dealings with Opus Genetics....

Continue Reading
Investigation Into Shareholder Claims Against AMLX, FIVE, HUM, and VSTS

Updated Category News Views 190

Grabar Law Office Investigates Shareholders' Rights Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX), Five Below, Inc. (NASDAQ: FIVE), Humana Inc. (NYSE: HUM), and Vestis Corp. (NYSE: VSTS) shareholders may have claims worth exploring. Grabar Law Office wants to inform these shareholders about the ongoing investigations into potential securities fraud that could have affected...

Continue Reading
Investors Seek Recovery in Class Action Against Paragon 28, Inc.

Updated Category News Views 109

Class Action Lawsuit Filed for Paragon 28, Inc. Investors We are reaching out to inform investors about an important class action securities lawsuit involving Paragon 28, Inc. This initiative aims to recover losses for investors who may have been adversely affected by purported securities fraud associated with the company. Details of the Class Action The class action...

Continue Reading
Alto Ingredients, Inc. Announcement for Q2 2025 Results

Updated Category News Views 165

Alto Ingredients, Inc. to Announce Second Quarter Financial Results Alto Ingredients, Inc. (NASDAQ: ALTO), a prominent producer and distributor of specialty alcohols and renewable fuels, is set to release its financial results for the second quarter of 2025. This announcement will take place after the market closes on Wednesday, August 6, 2025. Conference Call Details...

Continue Reading
Phare Bio Secures $27 Million to Revolutionize Antibiotic Discovery

Updated Category News Views 226

Phare Bio scored big back in 2024 with up to $27 million in funding from the Advanced Research Projects Agency for Health (ARPA-H). This isn’t just pocket change; it’s a lifeline aimed at supercharging their generative artificial intelligence (AI) platform. Teaming up with MIT's Collins Lab and Harvard's Wyss Institute, they set their sights on developing new classes...

Continue Reading